STRATA Skin Sciences Announces Third Quarter Financial Results
HORSHAM, Penn. — STRATA Skin Sciences, Inc. (“STRATA”, NASDAQ: SSKN) is set to reveal its financial results for the third quarter of 2025 on an important date. This report will be available to stakeholders after the market closes on November 13, 2025.
Details of the Financial Reporting
The management team at STRATA will conduct a conference call the same day at 4:30 p.m. ET, where they will delve into the financial performance and discuss vital corporate developments. This is not just a formal presentation; it will also include an interactive question-and-answer segment, providing an opportunity for participants to engage directly with the management.
How to Participate in the Conference Call
Stakeholders wishing to listen to the call can do so by dialing the domestic number at 1-866-524-3160 or the international line at 1-412-317-6760. Participants are encouraged to call in about 10 minutes early to ensure they can join the conversation smoothly.
Live Webcast Access
For those who prefer digital options, the conference call will also be streamed via a live webcast accessible through the STRATA Skin Sciences website. This allows attendees to engage with the updates in a more accessible format, ensuring that all interested parties can participate.
Replay Information
For individuals who might miss the live discussion, a telephonic replay will be accessible until November 20, 2025. Those wishing to listen can call 1-855-669-9658 domestically or 1-412-317-0088 internationally, along with the provided access code for easy retrieval. Additionally, a webcast replay will be available approximately one hour after the live event, with access lasting until May 13, 2026.
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is at the forefront of medical technology, focusing on innovative products for the treatment of various dermatological conditions. The company has built a reputation for its advanced solutions, including the XTRAC excimer laser, VTRAC lamp systems, and the TheraClear X Acne Therapy System. These technologies represent the cutting-edge of in-office dermatological treatments.
Unique Partnership Program
One of the standout features of STRATA's business model is its unique Partnership Program. This program offers flexible treatment cost structures rather than traditional equipment purchases, enabling practices to focus on patient care rather than upfront costs. The initiative includes comprehensive training for personnel, ongoing equipment service and maintenance, as well as dedicated customer service support.
Looking to the Future
As STRATA continues to grow, it remains dedicated to enhancing the patient experience and expanding its reach within the dermatology sector. The company's commitment to innovation, alongside its tailored partnership strategies, positions it well for future developments in skin health technology.
Frequently Asked Questions
What date will STRATA report its Q3 2025 financial results?
STRATA Skin Sciences will release its third quarter financial results on November 13, 2025.
How can I participate in the STRATA conference call?
To join the conference call, dial 1-866-524-3160 in the U.S. or 1-412-317-6760 internationally, about 10 minutes before the scheduled time.
Will there be a replay of the conference call?
Yes, a telephonic replay will be available until November 20, 2025. The replay can be accessed at 1-855-669-9658 (domestic) or 1-412-317-0088 (international).
What sets STRATA apart in the dermatology market?
STRATA’s innovative products and its unique Partnership Program stand out, allowing practices to offer advanced treatments without significant upfront costs.
How does STRATA support its partner practices?
STRATA provides training, ongoing support, and co-op advertising to help practices effectively implement and promote its dermatological technologies.
